Novartis | NOVN - Stock


Novartis reported $6.22B in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Alcon AG USD 2.44B 47M Mar/2026
Almirall EUR 178.13M 1.54M Dec/2025
Amgen USD 6.22B 34M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Autolus Therapeutics Ltd USD 33.43M 198K Jun/2026
Bayer EUR 11.97B 43M Jun/2026
Biogen USD 2.22B 159.9M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Fresenius EUR 2.73B 119M Mar/2026
Fresenius Medical Care EUR 2.33B 28.84M Jun/2026
Genmab DKK 21M 8M Mar/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
J&J USD 15.38B 233M Sep/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.78B 220M Mar/2026
Merck USD 6.21B 272M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Orion EUR 545.5M 33.3M Sep/2026
Pfizer USD 9.94B 722M Jun/2026
Philips EUR 3.22B 106M Jun/2026
Recordati EUR 550.34M 4.52M Jun/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024